Hepatitis Forums

Hepatitis C Main Forums => Hepatitis C Research News & Studies => Topic started by: Hep Editors on February 05, 2018, 10:18:50 am

Title: AbbVie’s Hep C Regimen Viekirax Is Safe, Effective Among Those With Kidney Disea
Post by: Hep Editors on February 05, 2018, 10:18:50 am

For people with genotype 1b of hepatitis C virus (HCV), having chronic kidney disease (CKD) does not affect the safety or efficacy of the hep C regimen Viekirax (ombitasvir/paritaprevir/ritonavir), Healio reports.

Publishing their findings in Hepatology Research, scientists conducted a retrospective multicenter study of 12 weeks of Viekirax treatment among 235 people with genotype 1b of HCV. 

Read more...
https://www.hepmag.com/article/abbvies-hep-c-regimen-viekirax-safe-effective-among-kidney-disease